SILVER SPRING, Md., Feb. 28, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced...
Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Roundup: February 28, 2025 )
Also on site :